Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MS
MS
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Novartis
MS
multiple sclerosis
Gilenya
Merck KGaA drops 10 per cent after drug rejection
FT.com
Fri, 09/24/10 - 09:57 am
Merck KGaA
MS
multiple sclerosis
Gilenya: A Blockbuster in Due Time
Motley Fool
Fri, 09/24/10 - 09:55 am
Gilenya
MS
multiple sclerosis
Novartis
Teva files new Copaxone lawsuit against Mylan
Yahoo/AP
Wed, 09/22/10 - 10:08 am
Teva Pharmaceuticals
Copaxone
patents
generics
MS
multiple sclerosis
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wed, 09/22/10 - 09:53 am
FDA
Gilenia
Novartis
Gilenya
MS
multiple sclerosis
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Minyanville
Tue, 09/21/10 - 09:19 am
Novartis
Gilenia
FDA
MS
multiple sclerosis
Xenoport rallies on drug update; indexes gain
Marketwatch
Mon, 09/13/10 - 12:53 pm
XenoPort
arbaclofen placarbil
MS
multiple sclerosis
Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
BNET Pharma
Fri, 09/10/10 - 11:10 am
M&A
Sanofi
Genzyme
teriflunomide
MS
Campath
multiple sclerosis
Teva Wins Copaxone Protection
Forbes
Tue, 09/7/10 - 05:03 pm
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents
Novartis
Momenta
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Bloomberg
Mon, 08/30/10 - 11:18 am
Sanofi
MS
teriflunomide
Merck KGaA
multiple sclerosis
Novartis
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Wed, 07/28/10 - 10:22 am
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
Merck KGaA expects MS pill to lift drugs margin
Reuters
Wed, 06/30/10 - 10:00 am
Merck KGaA
multiple sclerosis
Gilenia
MS
Merck Serono
cladribine
Elan Faces Double Threat To Blockbuster Drug Tysabri
WSJ
Thu, 06/17/10 - 11:32 am
Elan
MS
Tysabri
Biogen Idec
Novartis
Gilenia
Genzyme's MS drug gets FDA fast track
Yahoo/AP
Tue, 06/15/10 - 09:15 am
fast track
Genzyme
MS
multiple sclerosis
FDA
FDA Approval Positions Novartis in the Lead to Bring Oral MS Treatment to Market
Seeking Alpha
Mon, 06/14/10 - 12:05 pm
FDA
Novartis
MS
multiple sclerosis
FDA Panel Endorses Novartis Multiple Sclerosis Pill
Pharmalot
Thu, 06/10/10 - 08:38 pm
FDA
advisory panels
Novartis
MS
multiple sclerosis
Gilenia
FDA weighs benefits, risks of Novartis MS pill
Yahoo/AP
Tue, 06/8/10 - 06:57 pm
MS
FDA
multiple sclerosis
Gilenia
Merck KGaA again seeks U.S. nod for MS pill
Reuters
Tue, 06/8/10 - 08:37 am
Merck KGaA
multiple sclerosis
MS
cladribine
Biogen Idec Sues Other MS Drug Makers
WSJ Online
Wed, 06/2/10 - 05:16 pm
MS
multiple sclerosis
Biogen Idec
Pfizer
Bayer
Novartis
patents
beta-interferon
Safety Concerns Unlikely to Delay FDA Approval of Novartis' MS Drug Gilenia
BNET Pharma
Wed, 06/2/10 - 08:25 am
Novartis
MS
multiple sclerosis
Gilenia
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
next ›
last »